查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1854557

肾臟和泌尿系统器械市场：按产品、应用、最终用户、技术和分销管道划分 - 全球预测（2025-2032 年）

Nephrology & Urology Devices Market by Product, Application, End User, Technology, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，肾臟和泌尿系统器械市场规模将达到 404.2 亿美元，复合年增长率为 11.12%。

主要市场统计数据
基准年 2024 173.8亿美元
预计年份：2025年 193.6亿美元
预测年份：2032年 404.2亿美元
复合年增长率 (%) 11.12%

本文简要说明了人口压力、临床需求和技术融合如何重塑肾臟病学和泌尿系统器械策略。

在全球肾臟病和泌尿系统医疗设备领域，人口结构变化、临床需求和技术融合的驱动下，正经历一场剧烈的创新和结构性变革。慢性肾臟病的流行持续影响透析治疗的需求，而微创泌尿系统手术的进步正在重新定义肾结石、摄护腺疾病和尿失禁的治疗标准。同时，医疗服务模式的转变，包括居家护理、门诊外科手术和数位化随访，正迫使製造商和供应商重新思考产品设计、分销和支援服务。

投资者和临床领导者不仅要考虑设备性能，还要考虑生命週期经济效益、与数位平台的互通性以及影响产品上市时间的监管管道。随着成本控制和基于价值的采购日益强化，供应商与医院、透析中心和居家照护机构的关係越来越围绕配套服务和基本契约。因此，对于希望在该领域实现可持续差异化的相关人员而言，清晰了解临床工作流程、患者偏好和支付方动态至关重要。

这项措施凸显了报告的核心关注：不断变化的临床需求和技术发展轨迹如何与市场进入、供应链韧性和商业化策略相互交织。它也为更深入的分析奠定了基础，包括市场区隔、区域动态和竞争趋势，这些因素将在未来几年推动科技的普及应用。

微创手术、居家照护和数位医疗的融合如何重塑产品设计、照护管道和商业化模式

肾臟病和泌尿系统医疗设备领域正经历着技术、临床和商业性三方面的变革，这些变革正在重塑产品生命週期和医疗服务管道。微创技术、雷射和声波治疗方法的进步提高了手术的精准度，同时缩短了恢復时间，促使医院和门诊手术中心优先选择能够优化手术效率和患者体验的器械。同时，家庭透析治疗和可携式血液透析机系统的普及正在催生新的医疗模式，这些模式强调患者自主性和减轻医疗机构的负担，这也影响着器械的设计，使其更加註重安全性、易用性和远端监测功能。

整合感测器和连接功能的富数据设备能够实现预测性维护、个人化治疗和增强型临床监测。远端医疗整合和远端患者监护不再是辅助功能，而是许多寻求持续护理的终端使用者的核心需求。能够透过真实数据展示临床结果并提供全面培训和服务体系的製造商将拥有竞争优势。

在商业方面，分销管道正在不断演变，直销、专业分销商和数位市场都发挥互补作用。医疗系统和支付者越来越关注每次治疗的价值，这推动了对既能改善治疗效果又能降低总医疗成本的医疗器材的需求。这些相互交织的趋势迫使传统製造商和新参与企业都加快创新週期，建立策略伙伴关係关係，并重新评估定价和服务模式，以期实现长期应用。

评估2025年美国关税趋势将如何重塑设备产品线的采购、製造布局和商业谈判。

预计2025年美国贸易政策的调整和关税上涨正迫使製造商和供应链相关人员重新评估筹资策略、生产布局和定价方式。关税带来的成本压力可能会增加进口零件和成品的到岸成本，进而影响医院、透析中心和经销商的采购决策。为因应这项挑战，各公司正在探索近岸外包、供应商多元化和加强垂直整合等策略，以保障净利率并维持稳定的供应。

累积影响将因产品线而异。复杂的次组件和高重量比设备可能比耗材和散装产品面临不同的经济影响。采购团队可能会更专注于整体拥有成本，并寻求长期合约和替代采购方案以降低价格波动。同时，与生产转移或新供应商资格认证相关的监管和物流复杂性可能会导致更长的前置作业时间和额外的资本支出。

从策略角度来看，拥有灵活生产能力和完善品质系统的公司能够更好地吸收或抵消关税带来的成本变化，同时保持市场进入。与支付方和医疗系统合作，使报销模式与成本结构的变化相适应，可以减少实施过程中的摩擦。此外，积极沟通供应链风险缓解措施并保持库存计划透明的公司，将更有能力在政策主导的市场动盪中维护客户信心。

深入的細項分析，重点关注产品、应用、技术、终端用户和通路动态，这将决定临床和商业策略。

细分市场洞察揭示了因产品、应用、最终用户、技术和分销管道而异的细微需求驱动因素，这些因素都会影响研发重点和市场策略。在产品细分方面，导管和输尿管支架仍然是需求稳定的基本抛弃式，而内视镜和体外碎石机则在微创介入治疗已成为标准实践的地区优先考虑。透析设备组值得特别关注，因为它包括连续性肾臟替代疗法系统、血液透析机过滤器、血液透析机系统和腹膜透析系统。在血液透析机系统中，居家透析和中心透析之间的差异至关重要，这会影响自动化、安全连锁和远端监控等设备功能。

应用主导的细分明确了设备必须支援的临床管道。肾衰竭管理包括连续性肾臟替代疗法（CRRT）、血液透析机和腹膜透析，每种疗法都有不同的临床工作流程和资本投入。肾结石清除术区分体外震波碎石术和雷射碎石术，二者在资本投入和维护上也有差异。前列腺疾病和尿失禁的管理需要兼具诊断准确性和治疗效果的设备，这通常需要泌尿系统和尿失禁科之间的协作。

终端使用者细分进一步细化了市场格局：门诊手术中心、透析中心、居家照护机构和医院各自拥有不同的采购流程、人员配备模式和临床重点，这些因素决定了培训、服务和资金筹措需求。技术细分则突显了技术创新融合的领域——声波、电化学、雷射和超过滤技术——并展示了这些技术如何广泛应用于各种产品和应用需求。最后，分销管道细分——直销、分销商和电子商务——影响着买家体验和售后支援预期，其中数位化管道提高了透明度，并能更快地补充耗材。

美洲、欧洲、中东和非洲以及亚太地区在监管、报销和基础设施方面的差异将如何影响推广管道和商业性优先事项。

区域动态对三大主要区域丛集（美洲、欧洲、中东和非洲以及亚太地区）的普及曲线、监管严格程度和商业模式有显着影响。在美洲，成熟的医疗保健基础设施和不断扩展的居家医疗计划推动了家庭血液透析机和数位化设备的普及。区域内不同司法管辖区之间的差异则体现在报销模式和医院采购方式上，这些差异会影响普及的时间和规模。

欧洲、中东和非洲地区（EMEA）的监管和报销环境复杂多样，医疗器材核准严格，且各地区采用不同的医疗技术评估路径，这可能导致产品上市时间延长，但同时也为已证实具有临床和成本效益的产品提供奖励。在该地区的部分市场，公共预算的限制促使市场对具有明显效率提升或可应用于门诊病人的医疗设备的需求增加。此外，监管机构对病人安全和环境保护的重视也推动了对一次性产品转变为可重复使用产品的生命週期评估以及循环经济模式的关注。

亚太地区的特征是医疗体系快速现代化，同时又有大量服务不足的病患群体。透析基础设施和泌尿系统手术能力的投资正在不断扩大，而官民合作关係和政府主导的倡议往往加速了技术的应用。面向该地区的製造商必须平衡成本驱动的采购需求与建立强大的服务网络以及製定符合当地文化习惯的病人参与策略的需求。在所有地区，本地临床教育、经销伙伴和供应链韧性都是成功进入市场并实现规模化发展的关键因素。

竞争动态：现有企业、利基创新者和以服务主导的策略如何塑造产品系列、伙伴关係和市场差异化

肾臟病和泌尿系统医疗设备的竞争动态复杂多样，既有成熟的医疗技术巨头，也有专注于特定疗法和数位化復健的创新新兴企业。市场领导企业利用其规模优势，投资于整合设备、耗材和远端监测的整合系统，并与透析中心和医院建立稳固的服务关係。同时，一些专业公司则透过针对特定临床问题和营运限制的创新产品实现差异化竞争，例如一次性内视镜、先进的体外碎石技术和便携式家庭透析治疗平台。

策略活动主要围绕以下主题：整合策略性收购以填补产品组合缺口；与软体和资料分析供应商合作，将设备产生的资料转化为临床洞见；以及投资本地生产或提升製造弹性，以支援快速推出。随着客户日益重视执行时间和可预测的耗材供应，供应链伙伴关係和卓越的服务正成为越来越重要的竞争优势。能够证明已完成临床检验和监管应对力的新参与企业有可能颠覆传统的采购週期，但如何扩大商业营运规模并赢得机构投资者的信任仍然是关键的执行挑战。

最终，将差异化的临床表现与全面的生命週期支援（培训、维护、结果衡量）相结合的公司将最有希望赢得长期的客户关係，而敏捷的创新者将透过解决临床医生和患者的具体痛点来赢得快速的市场认可。

为製造商和医疗保健提供者制定切实可行的策略性倡议，以协调创新、供应链韧性和服务主导的商业化，从而确保可持续的市场优势。

行业领导者应优先考虑一系列切实可行的倡议，以确保在快速变化的环境中实现临床应用并保持营运韧性。首先，透过与临床医生共同设计设备，并融入远端监控和易用性功能以减轻培训负担，使研发投资与实际临床工作流程保持一致。其次，建立灵活的生产和供应网络，以降低关税和地缘政治风险，并在保证品质和合规性的前提下，实现跨区域的快速生产分配。

第三，我们将拓展以服务为导向的经营模式，将资本设备与耗材、培训和数位化监控结合，以创造差异化的价值提案和持续的收入来源。第四，我们将投资于可靠的真实世界证据项目和临床伙伴关係，以产生支持报销讨论和采购决策的疗效数据。第五，我们将根据终端用户群调整市场推广策略。例如，我们将优先在居家医疗环境中推广易于使用的家庭透析治疗系统，在医疗机构环境中推广高通量、耐用的设备。

最后，制定多通路分销策略，将复杂设备的直销与耗材和小型设备的经销商及电商通路结合，以增强商业灵活性。与客户就供应链优化措施进行透明沟通，并制定反映整体医疗成本降低而非仅仅单位成本降低的定价策略。这些措施将提高市场应对力，减少实施阻力，并协助企业实现永续成长。

一种稳健的实证方法，结合了针对临床医生的原始研究、全面的二手研究和严格的数据三角验证，以检验研究结果。

本分析的调查方法结合了定性研究、有针对性的二手研究以及严谨的三角验证，以确保研究结果具有可操作性且以证据为依据。主要资料来源包括对临床医生、医院和透析中心采购负责人、技术开发人员以及分销合作伙伴进行结构化访谈，以获取关于临床需求、应用障碍和服务期望的第一手观点。此外，还邀请了由执业肾臟科医生和泌尿系统组成的顾问小组对这些访谈进行审查，以检验临床相关性和手术趋势。

二级研究深入检视同行评审文献、监管指令、临床指南和公开白皮书，以确定临床和技术背景。透过与供应商揭露资讯、产品註册和专利状态进行交叉验证，整合市场状况。定量和定性输入资料进行三角验证以减少偏差，并透过情境分析对关键假设进行压力测试，重点关注供应链中断、政策变化和技术采纳率。

在整个过程中，资料品管包括来源检验、资料集一致性检查和内部同行评审。当资料粒度受专有资讯或快速变更的政策环境限制时，我们会承认其局限性，并鼓励随着新证据的出现定期更新资料。

本文综合分析了肾臟病和泌尿系统器械市场中，临床、技术和商业性三大要素交会点所决定的成功因素。

总而言之，肾臟病和泌尿系统器械市场正处于曲折点，人口结构变化、临床创新和不断变化的医疗模式既带来了机会，也带来了挑战。居家和微创治疗的兴起推动了对以患者为中心设计、具备互联性和易于维护的器械的需求。同时，商业性成功取决于能够将可验证的疗效、供应链的灵活性和产品经济效益与更广泛的医疗保健价值目标相结合的经营模式。

投资于灵活製造、强大的临床伙伴关係和完善的服务生态系统的相关人员将能够克服监管差异和政策主导的成本压力。按产品、应用、最终用户、技术和分销管道进行策略性细分，将有助于制定针对特定应用驱动因素的客製化方案。最后，随着医疗产业的现代化进程，就供应缓解措施和实际应用效果进行透明沟通，对于维护与医疗保健采购者和患者的信任仍然至关重要。

这些结论强调了整合策略的重要性，该策略应平衡技术创新、营运韧性和商业性适应性，以充分发挥肾臟病和泌尿系统医疗设备市场的潜力。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 人工智慧驱动的尿液生物标记分析平台可实现肾臟疾病的即时筛检
  • 开发具有可控按需药物释放型性能的可生物降解输尿管支架
  • 整合远端医疗平台，用于远距腹膜透析管理和病患教育
  • 采用3D列印患者特异性肾臟血管移植物进行复杂重组手术
  • 基于奈米颗粒的标靶药物传递系统在多囊性肾病变治疗的进展
  • 机器人辅助微创技术在复杂尿道结石和摄护腺手术的应用
  • 推出配备人工智慧超过滤和个人化治疗功能的智慧家用血液透析机机
  • 应用预测分析技术优化连续性肾臟替代疗法装置的液体清除。
  • 拓展数位健康应用，用于移植后泌尿系统病患的监测与遵从性管理

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

第八章 肾臟和泌尿系统器械市场（按产品划分）

  • 导管
  • 透析设备
    • 连续性肾臟替代疗法系统
    • 血液透析机过滤器
    • 血液透析机系统
      • 居家医疗
      • 中心设定
    • 腹膜透析系统
  • 内视镜检查
  • 碎石装置
  • 输尿管支架

9. 按应用分類的肾臟和泌尿系统器械市场

  • 肾衰竭管理
    • CRRT
    • 血液透析机
    • 腹膜透析
  • 肾结石清除
    • 体外震波碎石术
    • 雷射碎石术
  • 摄护腺疾病
  • 尿失禁管理

第十章 按最终用户分類的肾臟和泌尿系统器械市场

  • 门诊手术中心
  • 透析中心
  • 居家照护
  • 医院

第十一章 按技术分類的肾臟和泌尿系统器械市场

  • 声波技术
  • 电化学技术
  • 雷射技术
  • 超过滤技术

第十二章 肾臟及泌尿系统器械市场（依分销管道划分）

  • 直销
  • 经销商
  • 电子商务

第十三章：肾臟和泌尿系统器械市场（按地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 肾臟及泌尿系统器械市场（按类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国肾臟及泌尿系统器械市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Fresenius Medical Care AG & Co. KGaA
    • Baxter International Inc.
    • B. Braun Melsungen AG
    • Nipro Corporation
    • Asahi Kasei Corporation
    • Boston Scientific Corporation
    • Coloplast A/S
    • Teleflex Incorporated
    • Olympus Corporation
    • Cook Medical LLC
Product Code: MRR-F927BA462957

The Nephrology & Urology Devices Market is projected to grow by USD 40.42 billion at a CAGR of 11.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 17.38 billion
Estimated Year [2025] USD 19.36 billion
Forecast Year [2032] USD 40.42 billion
CAGR (%) 11.12%

A concise orientation to how demographic pressures, clinical demand, and technological convergence are reshaping nephrology and urology device strategies

The global landscape for nephrology and urology devices is undergoing a period of concentrated innovation and structural change driven by demographic pressures, clinical demand, and technological convergence. Chronic kidney disease prevalence continues to shape demand for dialysis modalities while advances in minimally invasive urologic procedures are redefining standards of care for kidney stones, prostate disorders, and urinary incontinence. Meanwhile, the shifting delivery models in healthcare-toward home-based therapies, ambulatory surgical care, and digitally enabled follow-up-are compelling manufacturers and providers to rethink product design, distribution, and support services.

Investors and clinical leaders must consider not only device performance but also lifecycle economics, interoperability with digital platforms, and regulatory pathways that influence product launch timing. As cost containment and value-based procurement intensify, supplier relationships with hospitals, dialysis centers, and home care providers are increasingly framed around bundled services and outcome-based contracting. Consequently, a clear understanding of clinical workflows, patient preferences, and payer dynamics is essential for stakeholders seeking durable differentiation in this sector.

This introduction frames the report's core focus on how evolving clinical needs and technological trajectories intersect with market access, supply chain resilience, and commercialization strategies. It sets the stage for deeper analyses on segmentation, regional dynamics, and the competitive plays that will drive adoption over the coming years.

How convergence of minimally invasive procedures, home-based therapies, and digital health is rewriting product design, care pathways, and commercialization models

The landscape of nephrology and urology devices is being transformed by an overlapping set of technological, clinical, and commercial shifts that are altering product life cycles and care pathways. Minimally invasive technologies and advances in laser and acoustic modalities are increasing procedural precision while reducing recovery times, prompting hospitals and ambulatory surgical centers to prioritize devices that optimize throughput and patient experience. Concurrently, the expansion of home-based dialysis and portable hemodialysis systems is unlocking new models of care that emphasize patient autonomy and reduced facility burden, which in turn influence device design for safety, ease of use, and remote monitoring.

Data-rich devices that integrate sensors and connectivity are enabling predictive maintenance, therapy personalization, and enhanced clinical oversight. Telehealth integration and remote patient monitoring are no longer auxiliary features but core expectations for many end-users seeking continuity of care. This shift to digitally augmented offerings is also changing commercialization strategies: manufacturers that can demonstrate clinical outcomes through real-world data and that provide comprehensive training and service ecosystems gain competitive advantage.

On the commercial front, distribution channels are evolving as direct sales, specialized distributors, and digital marketplaces each play complementary roles. Health systems and payers are increasingly focused on value per episode, driving demand for devices that lower total cost of care while improving outcomes. The intersection of these trends is forcing legacy manufacturers and new entrants alike to accelerate innovation cycles, form strategic partnerships, and re-evaluate pricing and service models to capture long-term adoption.

Assessing how the 2025 United States tariff trajectory will reshape sourcing, manufacturing footprints, and commercial negotiations across device product families

Anticipated tariff measures and trade policy shifts in the United States expected in 2025 are prompting manufacturers and supply-chain stakeholders to reassess sourcing strategies, production footprints, and pricing approaches. Tariff-driven cost pressures are likely to elevate the landed cost of imported components and finished devices, which will ripple through procurement discussions at hospitals, dialysis centers, and distributors. In response, companies are exploring nearshoring, supplier diversification, and increased vertical integration to protect margins and maintain predictable supply.

The cumulative impact will not be uniform across product families. Devices with complex subassemblies or high value-to-weight ratios will experience different economic effects than consumables or high-volume disposables. Procurement teams will intensify scrutiny of total cost of ownership and explore longer-term contracts or alternative sourcing arrangements to mitigate price volatility. At the same time, regulatory and logistical complexity associated with relocating production or qualifying new suppliers may extend lead times and require additional capital investment.

Strategically, firms with flexible manufacturing capabilities and robust quality systems will be better positioned to absorb or offset tariff-induced cost shifts while preserving market access. Collaboration with payers and health systems to align reimbursement models with altered cost structures can ease adoption friction. Moreover, companies that proactively communicate supply-chain risk mitigation and maintain transparent inventory planning will more effectively retain customer confidence during periods of policy-driven disruption.

Detailed segmentation analysis highlighting product, application, technology, end-user, and channel dynamics that determine clinical and commercial strategies

Segmentation insights reveal nuanced demand drivers that vary by product, application, end user, technology, and distribution channel, each influencing R&D focus and go-to-market strategy. Within product segmentation, Catheters and Ureteral Stents continue to be essential disposables with steady demand, while Endoscopes and Lithotripsy Devices are prioritized where minimally invasive interventions are standard practice. The Dialysis Devices group merits particular attention because it includes Continuous Renal Replacement Therapy systems, Hemodiafilters, Hemodialysis Systems, and Peritoneal Dialysis Systems; within Hemodialysis Systems, an important delineation exists between Home Settings and In-Center Settings, which affects device features such as automation, safety interlocks, and telemonitoring.

Application-driven segmentation underscores the clinical pathways that devices must support. Kidney Failure Management spans CRRT, Hemodialysis, and Peritoneal Dialysis, each with distinct clinical workflows and capital-intensity profiles. Kidney Stone Removal differentiates between Extracorporeal Shock Wave Lithotripsy and Laser Lithotripsy, leading to divergent capital equipment and maintenance considerations. Prostate Disorders and Urinary Incontinence Management demand devices that integrate diagnostic precision with therapeutic efficacy and often require coordinated care across urology and continence services.

End-user segmentation further refines market approach: Ambulatory Surgical Centers, Dialysis Centers, Home Care Settings, and Hospitals each present unique procurement processes, staffing models, and clinical priorities, which dictate training, service, and financing requirements. Technology segmentation highlights where innovation is concentrated, including Acoustic Wave Technologies, Electrochemical Technologies, Laser Technologies, and Ultrafiltration Technologies, and these modalities are unevenly distributed across product and application needs. Finally, distribution channel segmentation-comprising Direct Sales, Distributors, and Ecommerce-shapes buyer experience and post-sale support expectations, with digital channels increasing transparency and enabling faster replenishment for consumables.

How regional regulatory, reimbursement, and infrastructure differences across the Americas, Europe Middle East & Africa, and Asia-Pacific determine adoption pathways and commercial priorities

Regional dynamics shape adoption curves, regulatory rigor, and commercial models in meaningful ways across the three major geographic clusters of the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare infrastructure and expanding home-care initiatives are supporting growth in home hemodialysis adoption and digitally enabled device deployment, while procurement tends to emphasize lifecycle cost and proven clinical outcomes. Moving between jurisdictions within the region reveals differences in reimbursement models and hospital purchasing practices that influence timing and scale of adoption.

The Europe, Middle East & Africa complex presents a heterogeneous regulatory and reimbursement environment, where stringent device approvals and localized health technology assessment pathways can lengthen commercialization timelines but also reward demonstrable clinical and cost benefits. In some markets within this region, constrained public budgets push demand toward devices that offer clear efficiency gains or outpatient migration potential. The regulatory focus on patient safety and environmental stewardship also encourages single-use-to-reusable lifecycle evaluations and circular-economy considerations.

Asia-Pacific is characterized by a mix of rapidly modernizing healthcare systems and large, underserved patient populations. Investment in dialysis infrastructure and urology procedural capacity is expanding, and technology adoption is often accelerated by public-private partnerships and government-led initiatives. Manufacturers targeting this region must balance cost-sensitive procurement with the need for robust service networks and culturally tailored patient engagement strategies. Across all regions, localized clinical education, distribution partnerships, and supply-chain resilience are decisive factors for successful market entry and scaling.

Competitive dynamics showing how incumbents, niche innovators, and service-led strategies are shaping product portfolios, partnerships, and market differentiation

Competitive dynamics in nephrology and urology devices reflect a mix of established medtech incumbents, specialized device innovators, and agile emerging firms focused on niche therapies or digital habilitation. Market leaders are leveraging scale to invest in integrated systems that combine capital equipment, consumables, and remote monitoring, thereby creating sticky service relationships with dialysis centers and hospitals. Simultaneously, specialist companies are differentiating through targeted innovations-such as single-use endoscopes, advanced lithotripsy modalities, and compact home dialysis platforms-that address specific clinical pain points and operational constraints.

Strategic activity is concentrated around several themes: consolidation through strategic acquisitions to fill portfolio gaps; partnerships with software and data analytics providers to turn device-generated data into clinical insights; and investment in manufacturing flexibility to support regional production or rapid ramp-up. Supply-chain partnerships and service excellence are increasingly important competitive levers as customers prioritize uptime and predictable consumable supply. New entrants that can demonstrate clinical validation and regulatory readiness may disrupt traditional procurement cycles, but scaling commercial operations and establishing trust with institutional buyers remain significant execution challenges.

Ultimately, companies that combine differentiated clinical performance with comprehensive lifecycle support-training, maintenance, and outcome measurement-are best positioned to capture long-term customer relationships, while nimble innovators can win pockets of rapid adoption by solving specific clinician or patient pain points.

Actionable strategic initiatives for manufacturers and providers to align innovation, supply-chain resilience, and service-led commercialization for durable market advantage

Industry leaders should prioritize a set of actionable initiatives to secure clinical adoption and operational resilience in a rapidly evolving environment. First, align R&D investments with real-world clinical workflows by co-designing devices with clinicians and incorporating remote monitoring and usability features that reduce training burden. Second, build flexible manufacturing and supplier networks that permit rapid allocation of production across regions to mitigate tariff and geopolitical risk while maintaining quality and regulatory compliance.

Third, expand service-oriented business models that bundle capital equipment with consumables, training, and digital monitoring to create differentiated value propositions and recurring revenue streams. Fourth, invest in robust real-world evidence programs and clinical partnerships to generate outcome data that supports reimbursement discussions and procurement decisions. Fifth, tailor go-to-market approaches by end-user segment; for example, prioritize user-friendly home dialysis systems for home care settings and high-throughput, durable devices for in-center use.

Finally, strengthen commercial agility by developing multi-channel distribution strategies that combine direct sales for complex capital equipment with distributor and e-commerce channels for consumables and smaller devices. Cultivate transparent communications with customers about supply-chain mitigation, and design pricing strategies that reflect total cost of care improvements rather than unit price alone. Together, these actions will enhance market responsiveness, reduce adoption friction, and position organizations for sustainable growth.

A robust evidence-based approach combining primary clinician insights, comprehensive secondary research, and rigorous data triangulation to validate findings

The research methodology underpinning this analysis combines primary qualitative engagement, targeted secondary research, and rigorous triangulation to ensure findings are actionable and evidence-based. Primary inputs include structured interviews with clinicians, procurement leaders at hospitals and dialysis centers, technology developers, and distribution partners to capture firsthand perspectives on clinical needs, adoption barriers, and service expectations. These interviews are supplemented by advisory panel reviews with practicing nephrologists and urologists to validate clinical relevance and procedural trends.

Secondary research encompasses a thorough review of peer-reviewed literature, regulatory agency directives, clinical guidelines, and public-domain white papers to establish clinical and technological context. Market intelligence is then synthesized through cross-validation with supplier disclosures, product registrations, and patent landscapes where appropriate. Quantitative and qualitative inputs are triangulated to reduce bias, and key assumptions are stress-tested through scenario analysis focusing on supply-chain disruptions, policy shifts, and technology adoption rates.

Throughout the process, data quality controls include source verification, consistency checks across datasets, and internal peer reviews. Limitations are acknowledged where data granularity is constrained by proprietary information or rapidly evolving policy environments, and recommendations emphasize areas for periodic updates as new evidence emerges.

Concluding synthesis of the intersecting clinical, technological, and commercial imperatives that define success in nephrology and urology device markets

In summation, the nephrology and urology devices landscape is at an inflection point where demographic pressures, clinical innovation, and shifting care models converge to create both opportunity and complexity. The transition toward home-based therapies and minimally invasive interventions increases demand for devices that prioritize patient-centric design, connectivity, and simplified serviceability. At the same time, commercial success will hinge on demonstrable outcomes, supply-chain agility, and business models that align product economics with broader healthcare value objectives.

Stakeholders who invest in flexible manufacturing, strong clinical partnerships, and comprehensive service ecosystems will be better positioned to navigate regulatory variation and policy-driven cost pressures. Strategic segmentation-by product, application, end user, technology, and distribution channel-enables tailored approaches that address specific adoption drivers. Finally, transparent communication around supply mitigation and real-world performance will remain essential to maintaining trust with institutional buyers and patients as the sector modernizes.

These conclusions underscore the importance of an integrated strategy that balances innovation with operational resilience and commercial adaptability to capture the full potential of nephrology and urology device markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Artificial intelligence-driven urine biomarker analysis platforms enabling real-time kidney disease screening
  • 5.2. Development of biodegradable ureteral stents with controlled on-demand drug elution properties
  • 5.3. Introduction of wearable continuous renal function monitors for early chronic kidney disease detection
  • 5.4. Integration of telemedicine platforms in remote peritoneal dialysis management and patient coaching
  • 5.5. Adoption of 3D printed patient-specific renal vascular grafts for complex reconstructive procedures
  • 5.6. Advances in nanoparticle-based targeted drug delivery systems for polycystic kidney disease therapy
  • 5.7. Deployment of robotic-assisted minimally invasive technologies in complex urolithiasis and prostate surgeries
  • 5.8. Emergence of smart home hemodialysis devices with AI-powered ultrafiltration and treatment personalization
  • 5.9. Implementation of predictive analytics in continuous renal replacement therapy machines to optimize fluid removal
  • 5.10. Expansion of digital health applications for post-transplant urological patient monitoring and compliance management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Nephrology & Urology Devices Market, by Product

  • 8.1. Catheters
  • 8.2. Dialysis Devices
    • 8.2.1. CrRt Systems
    • 8.2.2. Hemodiafilters
    • 8.2.3. Hemodialysis Systems
      • 8.2.3.1. Home Settings
      • 8.2.3.2. In-Center Settings
    • 8.2.4. Peritoneal Dialysis Systems
  • 8.3. Endoscopes
  • 8.4. Lithotripsy Devices
  • 8.5. Ureteral Stents

9. Nephrology & Urology Devices Market, by Application

  • 9.1. Kidney Failure Management
    • 9.1.1. CrRt
    • 9.1.2. Hemodialysis
    • 9.1.3. Peritoneal Dialysis
  • 9.2. Kidney Stone Removal
    • 9.2.1. Extracorporeal Shock Wave Lithotripsy
    • 9.2.2. Laser Lithotripsy
  • 9.3. Prostate Disorders
  • 9.4. Urinary Incontinence Management

10. Nephrology & Urology Devices Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Dialysis Centers
  • 10.3. Home Care Settings
  • 10.4. Hospitals

11. Nephrology & Urology Devices Market, by Technology

  • 11.1. Acoustic Wave Technologies
  • 11.2. Electrochemical Technologies
  • 11.3. Laser Technologies
  • 11.4. Ultrafiltration Technologies

12. Nephrology & Urology Devices Market, by Distribution Channel

  • 12.1. Direct Sales
  • 12.2. Distributors
  • 12.3. Ecommerce

13. Nephrology & Urology Devices Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Nephrology & Urology Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Nephrology & Urology Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Fresenius Medical Care AG & Co. KGaA
    • 16.3.2. Baxter International Inc.
    • 16.3.3. B. Braun Melsungen AG
    • 16.3.4. Nipro Corporation
    • 16.3.5. Asahi Kasei Corporation
    • 16.3.6. Boston Scientific Corporation
    • 16.3.7. Coloplast A/S
    • 16.3.8. Teleflex Incorporated
    • 16.3.9. Olympus Corporation
    • 16.3.10. Cook Medical LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NEPHROLOGY & UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. NEPHROLOGY & UROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. NEPHROLOGY & UROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIAFILTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY IN-CENTER SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LITHOTRIPSY DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URETERAL STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY CRRT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PERITONEAL DIALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER LITHOTRIPSY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PROSTATE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY URINARY INCONTINENCE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ACOUSTIC WAVE TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ELECTROCHEMICAL TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY LASER TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ULTRAFILTRATION TECHNOLOGIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY ECOMMERCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 212. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 213. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 214. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 215. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 216. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 217. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 218. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 219. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 222. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 223. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 224. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 225. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 226. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 227. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 228. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 229. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. AMERICAS NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 236. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 237. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 238. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 239. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 242. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 243. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 244. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 245. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 246. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 247. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 250. NORTH AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 251. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 254. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 255. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 256. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 257. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 258. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 259. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 262. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 263. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 264. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 265. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 266. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 267. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. LATIN AMERICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY DIALYSIS DEVICES, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY HEMODIALYSIS SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY FAILURE MANAGEMENT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY KIDNEY STONE REMOVAL, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPE, MIDDLE EAST & AFRICA NEPHROLOGY & UROLOGY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPE, MI